Showing 2081-2090 of 5771 results for "".
- Hanita Lenses Announces Launch of Intensity IOLhttps://modernod.com/news/hanita-lenses-announces-launch-of-intensity-iol/2478082/After 3 years of development, Israel-based Hanita Lenses announced the launch of the Intensity IOL. The Intensity is a presbyopia-correcting IOL that has been developed by employing a proprietary iterative algorithm—called the Dynamic Light Utilization (DLU) technology—for better light eff
- Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indicationshttps://modernod.com/news/oculis-announces-successful-end-of-phase-2-meeting-with-the-fda-for-ocs-01-in-two-ophthalmology-indications/2478076/Oculis announced that it has successfully completed an end-of-phase 2 meeting with the FDA for OCS-01 in two indications: for the treatment of inflammation and pain following cataract surgery, and for the treatment of diabetic macular edema (DME). As a result, the company is currently planning th
- jCyte Announces Phase 2b Results of jCell Therapy in Retinitis Pigmentosahttps://modernod.com/news/jcyte-announces-phase-2b-results-of-jcell-therapy-in-retinitis-pigmentosa/2478078/jCyte Inc. announced promising results from a phase 2b clinical trial of jCell in retinitis pigmentosa (RP), irrespective of genetic subtype. jCell is a first-in-class investigational treatment for RP which has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation. In addi
- Lacrivera Announces CE Mark of the Vera180 Synthetic Absorbable Lacrimal Plughttps://modernod.com/news/lacrivera-announces-ce-mark-of-the-vera180-synthetic-absorbable-lacrimal-plug/2478063/Lacrivera announced CE Mark approval for the Vera180 synthetic absorbable lacrimal plug. The Vera180 provides extended temporary occlusion lasting approximately 180 days and is ideal for treatment of post-surgical dry eye and for treating the dry eye components of various ocular surface diseases,
- MeiraGTx Announces Positive Clinical Data of Investigational Gene Therapy for X-Linked Retinitis Pigmentosahttps://modernod.com/news/meiragtx-announces-positive-clinical-data-of-investigational-gene-therapy-for-x-linked-retinitis-pigmentosa/2478062/MeiraGTx Holdings announced 6-month data from the ongoing phase 1/2 clinical trial of AAV-RPGR, an investigational gene therapy in development for the treatment of patients with X-linked retinitis pigmentosa (XLRP) with genetically confirmed variants in the RPGR gene. Significant improve
- AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Programhttps://modernod.com/news/agtc-announces-updated-development-plan-for-its-x-linked-retinitis-pigmentosa-clinical-program/2478058/Applied Genetic Technologies Corporation announced next steps in the clinical development of the company’s potential treatment of X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene following receipt of written feedback from the FDA. The revised development p
- EyeCare Partners Announces Completion of Six New Practice Acquisitions in Second Quarterhttps://modernod.com/news/eyecare-partners-announces-completion-of-six-new-practice-acquisitions-in-second-quarter/2478055/EyeCare Partners (ECP) announced the acquisition of six new optometry, ophthalmology and eye surgery centers in regional markets around the country. ECP closed on the following acquisitions during the second quarter: Vitreous Retina Macula Specialists of New Jersey in Somerset, New J
- Norlase Announces CE Mark Approval for LEAF Green Laserhttps://modernod.com/news/norlase-announces-ce-mark-approval-for-leaf-green-laser/2478045/Norlase announced that it has been granted the CE Mark approval for the LEAF, a first in class, fiberless green laser for the treatment of retina and glaucoma diseases. The CE Mark follows the recent FDA 510(k) market clearance of the LEAF and ISO 13485:2016 certification of Norlase’s medical dev
- Alcon to Showcase Latest Innovations, Data at ASRS 2020 Virtual Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-data-at-asrs-2020-virtual-annual-meeting/2478040/Alcon will present key data highlighting advancements in vitreoretinal surgery during the American Society of Retina Specialists (ASRS) 2020 virtual annual meeting, taking place July 24-26. New data about the effectiveness of the Hypervit Dual Blade Vitrectomy Probe and other retina surgical plat
- National Vision Announces Special Cash Bonus to Front-Line Associates and Doctorshttps://modernod.com/news/national-vision-announces-special-cash-bonus-to-front-line-associates-and-doctors/2478032/National Vision Holdings announced plans to grant a special cash bonus to front-line associates and doctors. A one-time $250 bonus will be given to all patient-facing and customer-facing associates and the company’s network of doctors in recognition of their hard work and dedication toward